This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hüebner, C. Articles by Ferguson, L. R. Search for Related Content PubMed PubMed Citation Articles by Hüebner, C. Articles by Ferguson, L. R. Related Collections Epidemiology Epidemiology: Molecular Epidemiology

Triallelic Single Nucleotide Polymorphisms and Genotyping Error in Genetic Epidemiology Studies: MDR1 (ABCB1) G2677/T/A as an Example

¹ Discipline of Nutrition and ² Department of Obstetrics and Gynecology, Faculty of Medical and Health Sciences and ³ Department of Statistics, Faculty of Science, The University of Auckland and ⁴ Nutrigenomics New Zealand, Auckland, New Zealand

Requests for reprints: Lynnette R. Ferguson, Discipline of Nutrition, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand. Phone: 6493737599, ext. 86372; Fax: 6493035962. E-mail: l.ferguson{at}auckland.ac.nz

Accurate measurement of allele frequencies between population groups with differing sensitivities to disease is fundamental to genetic epidemiology. Genotyping errors can markedly influence the biological conclusions of a study. This issue may be especially important now there is increasing recognition of triallelic single nucleotide polymorphisms (SNPs) in the genome and their possible role in diseases like inflammatory bowel disease. For example, the MDR1 (ABCB1) SNP G2677/T/A was, like many other triallelic SNPs, originally described as diallelic. Here, we report a comprehensive analyses of estimated allele frequencies of this SNP in a set of 73 human DNA samples, comparing six commonly used genotyping methods (Applied Biosystems Taqman, Roche LightCycler melting analysis, allelic discrimination PCR, DNA sequencing, Sequenom, and RFLP) from the angle of their error potential. Only Sequenom and DNA sequencing provided accurate measurements, if we had not had prior knowledge of the triallelic nature of this SNP. The other tested methods (with the exception of LightCycler) failed to show any indication of the presence of the rare third A- allele in a diallelic assay. Although most of the errors were due to the inability to detect the third allele, all methods except Sequenom and sequencing produced errors for the detection of the two common alleles G and T (LightCycler, 6 errors; PCR, 4 errors; RFLP, 2 errors; Taqman, 1 error). There is considerable variability in the reported frequencies of the different alleles of the MDR1 G2677/T/A SNP, and the role of this SNP in the etiology of inflammatory bowel disease has been controversial. Our data emphasize the importance of choosing the appropriate method for SNP detection and lead us to suggest that part of the previously reported variation may reflect artifacts associated with the different genotyping methodologies used. The failure to recognize the triallic nature of a SNP may lead to underestimations of real genetic associations. (Cancer Epidemiol Biomarkers Prev 2007;16(6):1185–92)